Guest Blogs
-
Novel Clinical Trials: Re-imagining An mRNA-Based Lyme Disease Vaccine Using Tick Saliva
2/3/2022
Discover how a new mRNA vaccine may introduce a novel way to prevent the transmission of Lyme disease and other tick-borne illnesses.
-
Consensus Drives Collaboration: In-Depth Cell Analysis Can Accelerate Understanding Of The Brain
1/5/2022
A large team of researchers has made great strides in developing a census and atlas of the cell types found in the mammalian primary motor cortex, advancing efforts to classify the vast complex network of diverse brain cells. Find out more about this discovery in the available blog post.
-
Three New Keys Found To "Switch Tracks" In Mental Health Patients' Train Of Thought
1/5/2022
A proof-of-concept study of brain stimulation among patients with epilepsy may have revealed a revolutionary way to treat people with severe depression, anxiety, addiction and other mental disorders. Read this blog post to find out more.
-
When NSAAs Enter the Mix, Protein Therapeutics May Thrive
12/1/2021
Protein therapeutics may soon represent a $200 billion market despite a few inherent limitations. Read how the inefficient processes surrounding this may be a thing of the past.
-
Five New Gene Therapies For Sickle Cell Disease Currently In Clinical Trials
12/1/2021
While candidates in the pipeline show great promise for a gene-based treatment for sickle cell disease, the challenges facing the practical use of any such innovations may get in the way of changing the global impact of this disease.
-
New Hope For Ultra-Rare Childhood Disease
12/1/2021
Find out how the recent release of findings from a small Phase 1 clinical trial not only gives hope to families affected by an ultra-rare childhood disease, but may also offer a glimpse into future treatment of genetic disorders affecting the central nervous system.
-
CRISPR And The Continuing Quest For CAR-T Safety And Durability
11/5/2021
In this blog, explore the evolution of an allogeneic CAR-T program, which could result in a large batch of “universal” therapy based on donor cells as opposed to a customized batch for an individual patient.
-
mRNA Gene Therapy: Early Phase Development
11/5/2021
Researchers have been exploring ways to leverage mRNA’s protein-making abilities to create enzymes to treat rare diseases as well as agents to promote growth and restore cardiac tissue. In this blog, read about the evolution of mRNA therapies and the challenges that researchers will need to overcome to ensure mRNA’s successful application.
-
Introduction To Innovative Gene Therapy Using Anelloviruses
9/28/2021
Biotech start-up Ring Therapeutics, founded by Flagship Pioneering in 2017, hopes to transform gene therapy by using a new class of vector — anelloviruses – a diverse family of harmless viruses present in the human body.
-
Real-World Data: Sequencing Exomes To Treat Obesity
9/28/2021
An estimated 650 million adults live with obesity today, which puts those individuals at increased risk for some of the leading causes of death worldwide, including diabetes, heart disease, stroke, and some types of cancer. According to a new study published in Science, treating obesity may soon rely on a genetic target.